Neuronetics, Inc. Common Stock (STIM)
Neuronetics, Inc. is a medical technology company specializing in developing and commercializing neurostimulation devices for the treatment of mental health and neurological conditions. The company is best known for its NeuroStar Advanced Therapy System, which offers non-invasive transcranial magnetic stimulation (TMS) therapy primarily for the treatment of major depressive disorder. Neuronetics aims to provide innovative solutions that improve patient outcomes and expand access to mental health treatments.
Company News
Neuronetics, Inc. has successfully completed the acquisition of Greenbrook TMS Inc. The combined company will continue to operate as Neuronetics, Inc. and the Neuronetics shares will continue to trade on the NASDAQ Global Market under the ticker 'STIM'.
Neuronetics (STIM) announces the nationwide launch of the Better Me Provider (BMP) program developed in collaboration with TMS medical experts. The BMP program will be part of the company's NeuroStar product line.
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action...
STIM earnings call for the period ending June 30, 2022.
3 biotech penny stocks to watch after Bellus Health (BLU) skyrockets. The post Biotech Penny Stocks To Buy After BLU Stock Explodes? 3 To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.